1. Home
  2. HUIZ vs GBIO Comparison

HUIZ vs GBIO Comparison

Compare HUIZ & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huize Holding Limited

HUIZ

Huize Holding Limited

N/A

Current Price

$1.98

Market Cap

31.5M

Sector

Finance

ML Signal

N/A

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.62

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUIZ
GBIO
Founded
2006
2016
Country
China
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.5M
36.3M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
HUIZ
GBIO
Price
$1.98
$5.62
Analyst Decision
Hold
Buy
Analyst Count
1
5
Target Price
$2.30
$8.88
AVG Volume (30 Days)
7.5K
104.8K
Earning Date
03-23-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
$186,519,166.00
$15,270,000.00
Revenue This Year
$22.67
N/A
Revenue Next Year
$8.55
N/A
P/E Ratio
$7.97
N/A
Revenue Growth
19.12
N/A
52 Week Low
$1.50
$3.00
52 Week High
$4.53
$8.43

Technical Indicators

Market Signals
Indicator
HUIZ
GBIO
Relative Strength Index (RSI) 29.92 52.92
Support Level $1.86 $5.44
Resistance Level $2.25 $5.73
Average True Range (ATR) 0.12 0.14
MACD 0.02 -0.00
Stochastic Oscillator 26.67 68.75

Price Performance

Historical Comparison
HUIZ
GBIO

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: